A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Yale University
Immatics US, Inc.
Genmab
M.D. Anderson Cancer Center
Alpha Tau Medical LTD.
Prescient Therapeutics, Ltd.
Bayer
Daiichi Sankyo
Chengdu Zenitar Biomedical Technology Co., Ltd
ModernaTX, Inc.
CytomX Therapeutics
OncoNano Medicine, Inc.
Alpha Tau Medical LTD.
Novelwise Pharmaceutical Corporation
Treeline Biosciences, Inc.
Lyell Immunopharma, Inc.
City of Hope Medical Center
Biogen
City of Hope Medical Center
Yale University
University of Aarhus
Vastra Gotaland Region
Stanford University
University College, London
Melanoma and Skin Cancer Trials Limited
BeiGene
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
Kyowa Kirin Co., Ltd.
National Cancer Institute (NCI)
Zai Lab (Hong Kong), Ltd.
Bristol-Myers Squibb
Nektar Therapeutics
Atara Biotherapeutics
Roswell Park Cancer Institute
Peter MacCallum Cancer Centre, Australia
University of Kansas Medical Center
Provectus Pharmaceuticals
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
University of Michigan Rogel Cancer Center
Novartis
Incyte Corporation
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center